Related Experiment Video
Updated: Jun 3, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Antiviral activities in human saliva
D Malamud1, W R Abrams, C A Barber
1Department of Basic Sciences, NYU College of Dentistry, New York, New York, USA. daniel.malamud@nyu.edu
Human saliva contains antibacterial and antiviral proteins, including gp340 (salivary agglutinin). This protein inhibits HIV-1 and influenza A in saliva but promotes HIV-1 infection when cell-bound in the reproductive tract.
Area of Science:
- Oral biology
- Immunology
- Microbiology
Background:
- Human saliva possesses numerous proteins with antibacterial and antiviral properties.
- Many antibacterial proteins in saliva also exhibit antiviral activity against specific viral pathogens.
- The glycoprotein gp340 (salivary agglutinin) is a key protein interacting with both bacteria and viruses.
Purpose of the Study:
- To review the antibacterial and antiviral proteins in human saliva.
- To focus on the dual role of gp340 in oral and reproductive health.
- To explore the mechanisms of gp340's interaction with bacteria and viruses.
Main Methods:
- Literature review of studies on salivary proteins.
- Analysis of gp340's function in different biological contexts.
- Examination of gp340's binding and aggregation properties with bacteria and viruses.
Main Results:
- Most antibacterial salivary proteins also show antiviral activity.
- Soluble gp340 aggregates bacteria for clearance in the mouth but promotes adherence when tooth-bound.
- Soluble gp340 inhibits HIV-1 and influenza A infectivity in the oral cavity.
- Cell-bound gp340 in the female reproductive tract promotes HIV-1 infection.
Conclusions:
- Gp340 exhibits context-dependent functions, acting as an antiviral agent in saliva and a facilitator of viral infection when cell-bound.
- The dual role of gp340 highlights the complexity of host-pathogen interactions in different mucosal environments.
- Further research into gp340's mechanisms could inform strategies for controlling oral and reproductive tract infections.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Herpes
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles

